Evidence map›Paper›PMID 34768898›Full record

ArticleInternational journal of molecular sciences2021

Overexpression of

Kamonchanock Eungrasamee, Aran Incharoensakdi, Peter Lindblad, Saowarath Jantaro

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Triple-Gene Overexpression of the AcrA-AcrB-TolC Transporter System inInternational journal of molecular sciences · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Increased Biomass and Polyhydroxybutyrate Production byInternational journal of molecular sciences · 2023
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Kamonchanock EungrasameeLaboratory of Cyanobacterial Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.
Aran IncharoensakdiLaboratory of Cyanobacterial Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.
Peter LindbladMicrobial Chemistry, Department of Chemistry-Ångström, Uppsala University, Box 523, SE-75120 Uppsala, Sweden.ORCID 0000-0001-7256-0275
Saowarath JantaroLaboratory of Cyanobacterial Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-9259-9684
Chulalongkorn University · THUppsala University · SE

Funding

Chulalongkorn University CU_GR_62_25_23_08Chulalongkorn University Second Century Fund, C2F C2F-2020the Development and Promotion of Science and Technology Talents Project (DPST)'s scholarship DPST
6 · The paper itself

Abstract

Although engineered cyanobacteria for the production of lipids and fatty acids (FAs) are intelligently used as sustainable biofuel resources, intracellularly overproduced FAs disturb cellular homeostasis and eventually generate lethal toxicity. In order to improve their production by enhancing FFAs secretion into a medium, we constructed three engineered

Indexed as

LipogenesisMutationBacterial ProteinsFatty Acids, NonesterifiedMembrane LipidsSynechocystisBacterial ProteinsFatty Acids, NonesterifiedMembrane Lipidsacyl-ACP synthetaseFFA secretionlipase Amembrane lipid degradationSynechocystis sp. PCC 6803

Identifiers

PMID34768898
PMCPMC8583886
OpenAlexW3210605074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.